News AstraZeneca PLC

Equities

AZN

GB0009895292

Real-time Estimate Cboe Europe Other stock markets 09:03:40 2024-05-15 am EDT			5-day change	1st Jan Change
12,171 ^GBX	-0.61%		-0.72%	+14.87%

10:04am	ASTRAZENECA : UBS reiterates its Sell rating	ZD
May. 14	FDA extends review of Ascendis Pharma's hormone disorder therapy	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ASTRAZENECA : UBS reiterates its Sell rating	04:04am	ZD
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg elected as a new board member	04:00am	AQ
FDA extends review of Ascendis Pharma's hormone disorder therapy	May. 14	RE
ASTRAZENECA : Buy rating from JP Morgan	May. 14	ZD
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	May. 13
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit -- 2nd Update	May. 13	DJ
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit -- Update	May. 13	DJ
Cinven to explore $3 billion sale of software maker Jaggaer, sources say	May. 13	RE
Pfizer, AstraZeneca, Morgan Stanley Pledge Investments, Jobs to France	May. 13	MT
France Secures Billions at Foreign Investment Summit	May. 13	DJ
France gets $16 billion of foreign investments as part of 'Choose France' event	May. 13	RE
AstraZeneca Pledges $388 Million Investment at French Site	May. 12	MT
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France	May. 12	RE
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	May. 08	MT
AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement	May. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT